Owner Abbott Biotechnology Ltd.

Inventors Mankovich, John A.; Vaughan, Tristan J.; Salfeld, Jochen G.; Hoogenboom, Hendricus R.J.M.; Allen, Deborah J; McGuiness, Brian T.; Kaymakcalan, Zehr; Schoenhaut, David; Roberts, Andrew J.; Labkovsky, Boris; White, Michael; Wilton, Alison J.; Sakorafas, Paul

Agent Shelston IP

Pub. Number AU-B-2006241387

Parent 2004202769

Filing date 24 November 2006

Wipo publication date 14 December 2006

Acceptance publication date 23 July 2009

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/64 (2006.01) Mutation or genetic engineering - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids